[Physiological and pharmacological aspects of fibrinolysis].
作者信息
Fearnley G R
出版信息
Clin Ter. 1971 May 15;57(3):205-25.
PMID:5110942
Abstract
摘要
相似文献
1
[Physiological and pharmacological aspects of fibrinolysis].
Clin Ter. 1971 May 15;57(3):205-25.
2
Fibrinolysis.
Adv Drug Res. 1973;7:107-63.
3
Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
Postgrad Med J. 1969 May;45:52-62.
4
Fibrinolytic effect of biguanides.
Ann N Y Acad Sci. 1968 Mar 26;148(3):840-7. doi: 10.1111/j.1749-6632.1968.tb27757.x.
5
[Non-enzymatic fibrinolytic agents].
Ann Anesthesiol Fr. 1978;19(8):697-702.
6
Pharmacological fibrinolysis.
Acta Univ Carol Med Monogr. 1972;52:15-7.
7
Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):223-9.
8
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
Scand J Haematol. 1970;7(5):404-8. doi: 10.1111/j.1600-0609.1970.tb01922.x.
9
Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.
Lancet. 1968 Nov 9;2(7576):1004-7. doi: 10.1016/s0140-6736(68)91297-x.
10
Fibrinolysis and its pharmacological enhancement in occlusive vascular disease.
Adv Cardiol. 1970;4:211-24. doi: 10.1159/000387617.
Zotero 插件